Association of metabolic syndrome with neuroimaging and cognitive outcomes in the UK Biobank
Résumé fourni par la source
Objective: Metabolic syndrome (MetS) has been previously linked to dementia. This study examines the association of MetS with neuroimaging and cognition in dementia-free adults, offering insight into the impact of MetS on brain health prior to dementia onset. Research Design and Methods: We included 37,395 dementia-free adults from the UK Biobank. MetS was defined as ≥3 of the following components: elevated waist-circumference, triglycerides, blood-pressure, HbA1c, or reduced HDL-cholesterol. Multivariable-adjusted linear regression was used to assess associations of MetS with structural neuroimaging and cognitive domains. Results: MetS was associated with lower total brain (Standardised Beta-coefficient (β): -0.06, 95%CI: -0.08, -0.04), grey matter (β: -0.10, 95%CI: -0.12, -0.08) and hippocampal volumes (Left-β: -0.03, 95%CI: -0.05, -0.01; Right-β: -0.04, 95%CI: -0.07, -0.02), and greater white matter hyperintensities (WMH) volume (β: 0.08, 95%CI: 0.06, 0.11). MetS participants performed poorer on cognitive tests of working memory (β: -0.10, 95%CI: -0.13, -0.07), verbal-declarative memory (β: -0.08, 95%CI: -0.11, -0.05), processing speed (β: -0.06, 95%CI: -0.09, -0.04), verbal and numerical reasoning (β: -0.07, 95%CI: -0.09, -0.04), non-verbal reasoning (β: -0.03, 95%CI: -0.05, -0.01), and on executive function, where higher scores indicated poorer performance (β: 0.05, 95%CI: 0.03, 0.08). An increasing number of MetS components were also associated with lower brain volumes, greater WMH, and poorer cognition across all domains. Conclusions: MetS was associated poorer brain health in dementia-free adults, characterised by lower brain volumes, greater vascular pathology, and poorer cognition. Further research is necessary to understand whether reversal or improvement of MetS can improve brain health.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Association of metabolic syndrome with neuroimaging and cognitive outcomes in the UK Biobank
- Date Crossref
- 19/06/2024
- Éditeur
- American Diabetes Association
- Type
- posted-content
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.